Press Releases

2/28/2008 Javelin Pharmaceuticals, Inc. Vice President to Assume Consultant Role	7.6 KB
2/28/2008 Javelin Pharmaceuticals Regains Compliance with Amex Director Independence Rules	8.2 KB
2/25/2008 Javelin Pharmaceuticals Completes Subject Accrual for all Pharmacokinetic Clinical Studies of PMI-150	9.9 KB
2/22/2008 Javelin Pharmaceuticals to Host Year End Conference Call	7.9 KB
2/19/2008 Javelin Pharmaceuticals Names Peter Kiernan to Board of Directors	8.7 KB
1/22/2008 Javelin Pharmaceuticals Expands Patent Protection for PMI-150 in Canada	8.6 KB
1/8/2008 Javelin Pharmaceuticals' Latest Study of Dyloject(TM) Confirms Minimal Effect on Platelet Function, Differentiating Dyloject from Ketorolac and Aspirin	9.6 KB
1/7/2008 Javelin Pharmaceuticals CEO to Present at JPMorgan's 26th Annual Healthcare Conference	7.4 KB
12/19/2007 Javelin Pharmaceuticals Announces Peer-Reviewed Publication of Successful Postoperative Pain Trial with PMI-100/150 (Intranasal Ketamine) in International Journal, ''Acute Pain''	11.1 KB
12/14/2007 Javelin Pharmaceuticals Dyloject(R) Added to Hospital Formulary in UK	10.2 KB
12/14/2007 Javelin Pharmaceuticals Announces Successful Dyloject Pivotal US Phase 3 Trial Top-Line Results at New York City Analyst Day	12.1 KB
12/11/2007 Javelin Pharmaceuticals Launches Dyloject(R) in UK	10.0 KB
11/30/2007 Javelin Pharmaceuticals, Inc. to Host 2007 Analyst and Institutional Investor Day	8.6 KB
11/2/2007 Javelin Pharmaceuticals, Inc. to Present at Two Upcoming Healthcare Conferences in November	7.4 KB
11/1/2007 Javelin Pharmaceuticals Reports Third Quarter Results for 2007	13.1 KB
10/31/2007 Javelin Pharmaceuticals Receives Marketing Authorization Approval for Dyloject® in the United Kingdom	12.3 KB
10/25/2007 Javelin Pharmaceuticals to Host Quarterly Conference Call	8.7 KB
9/27/2007 Javelin Pharmaceuticals, Inc. Granted Commercially Important U.S. Patent for Intranasal Ketamine	9.4 KB
9/24/2007 Javelin Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference	7.6 KB
9/20/2007 Javelin Pharmaceuticals, Inc. to be Honored as NIH-NCI-SBIR Tibbetts Award Winner	9.4 KB
Showing 61-80 of 156 releases Page: 1 2 3 4 5 6 7 8  See Previous 20 | See Next 20

CONTACT US   JOIN US   SITE MAP
© 2010 Javelin Pharmaceuticals,Inc. / Intrac,Inc. / IDDS,Inc. All rights reserved. All other trademarks are the properties of their respective owners. Reproduction in whole or in part in any form or medium without express written permission of Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. is prohibited.